Phage Therapy, Precision Medicine – Innovative Treatment Options To Combat Multidrug-Resistant Tuberculosis

In 2022, the number of patients with multidrug-resistant tuberculosis in India increased by 32 per cent, compared to 2021. This means that there were over 1,57,000 cases of the disease in 2022.

Multidrug-resistant tuberculosis is a major health threat because Mycobacterium tuberculosis, the pathogen responsible for tuberculosis, becomes resistant to the two most potent drugs against the disease, making it difficult to treat patients.

Source : Getty/ABP Live

Multidrug-resistant tuberculosis is a major health threat because Mycobacterium tuberculosis, the pathogen responsible for tuberculosis, becomes resistant to the two most potent drugs against the disease, making it difficult to treat patients. Tuberculosis is an air-borne disease that primarily affects the lungs, but can also impact other body parts such as the brain, kidneys, or spine. According to the Global TB Report 2022, the estimated incidence of multidrug-resistant tuberculosis in 2021 in